BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11297678)

  • 1. Roles of the H-2D(b) and H-K(b) genes in resistance to persistent Theiler's murine encephalomyelitis virus infection of the central nervous system.
    Azoulay-Cayla A; Syan S; Brahic M; Bureau JF
    J Gen Virol; 2001 May; 82(Pt 5):1043-1047. PubMed ID: 11297678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H-2D(b-/-) mice are susceptible to persistent infection by Theiler's virus.
    Azoulay-Cayla A; Dethlefs S; PĂ©rarnau B; Larsson-Sciard EL; Lemonnier FA; Brahic M; Bureau JF
    J Virol; 2000 Jun; 74(12):5470-6. PubMed ID: 10823851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capsid-specific cytotoxic T lymphocytes recognize three distinct H-2D(b)-restricted regions of the BeAn strain of Theiler's virus and exhibit different cytokine profiles.
    Lyman MA; Lee HG; Kang BS; Kang HK; Kim BS
    J Virol; 2002 Apr; 76(7):3125-34. PubMed ID: 11884537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The majority of infiltrating CD8+ T cells in the central nervous system of susceptible SJL/J mice infected with Theiler's virus are virus specific and fully functional.
    Kang BS; Lyman MA; Kim BS
    J Virol; 2002 Jul; 76(13):6577-85. PubMed ID: 12050370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma interferon is critical for neuronal viral clearance and protection in a susceptible mouse strain following early intracranial Theiler's murine encephalomyelitis virus infection.
    Rodriguez M; Zoecklein LJ; Howe CL; Pavelko KD; Gamez JD; Nakane S; Papke LM
    J Virol; 2003 Nov; 77(22):12252-65. PubMed ID: 14581562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Theiler's virus alternatively initiated protein inhibits the generation of H-2K-restricted virus-specific cytotoxicity.
    Lin X; Roos RP; Pease LR; Wettstein P; Rodriguez M
    J Immunol; 1999 Jan; 162(1):17-24. PubMed ID: 9886365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow chimeras reveal non-H-2 hematopoietic control of susceptibility to Theiler's virus persistent infection.
    Aubagnac S; Brahic M; Bureau JF
    J Virol; 2002 Jun; 76(11):5807-12. PubMed ID: 11992010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional Silencing of H-2D
    Tritz ZP; Orozco RC; Malo CS; Ayasoufi K; Fain CE; Khadka RH; Goddery EN; Yokanovich LT; Settell ML; Hansen MJ; Jin F; Pavelko KD; Pease LR; Johnson AJ
    J Immunol; 2020 Sep; 205(5):1228-1238. PubMed ID: 32737149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon alpha/beta mediates early virus-induced expression of H-2D and H-2K in the central nervous system.
    Njenga MK; Pease LR; Wettstein P; Mak T; Rodriguez M
    Lab Invest; 1997 Jul; 77(1):71-84. PubMed ID: 9251680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice.
    Njenga MK; Pavelko KD; Baisch J; Lin X; David C; Leibowitz J; Rodriguez M
    J Virol; 1996 Mar; 70(3):1729-37. PubMed ID: 8627694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential generation of class I H-2D- versus H-2K-restricted cytotoxicity against a demyelinating virus following central nervous system infection.
    Lin X; Pease LR; Rodriguez M
    Eur J Immunol; 1997 Apr; 27(4):963-70. PubMed ID: 9130651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The level of viral infection of antigen-presenting cells correlates with the level of development of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Jin YH; Kang HS; Hou W; Meng L; Kim BS
    J Virol; 2015 Feb; 89(3):1867-78. PubMed ID: 25428872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in avidity and epitope recognition of CD8(+) T cells infiltrating the central nervous systems of SJL/J mice infected with BeAn and DA strains of Theiler's murine encephalomyelitis virus.
    Kang BS; Lyman MA; Kim BS
    J Virol; 2002 Nov; 76(22):11780-4. PubMed ID: 12388742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clearance of Theiler's virus infection depends on the ability to generate a CD8+ T cell response against a single immunodominant viral peptide.
    Mendez-Fernandez YV; Johnson AJ; Rodriguez M; Pease LR
    Eur J Immunol; 2003 Sep; 33(9):2501-10. PubMed ID: 12938226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalent class I-restricted T-cell response to the Theiler's virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28.
    Johnson AJ; Njenga MK; Hansen MJ; Kuhns ST; Chen L; Rodriguez M; Pease LR
    J Virol; 1999 May; 73(5):3702-8. PubMed ID: 10196262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The infection of mouse by Theiler's virus: from genetics to immunology.
    Monteyne P; Bureau JF; Brahic M
    Immunol Rev; 1997 Oct; 159():163-76. PubMed ID: 9416510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FVB mice transgenic for the H-2Db gene become resistant to persistent infection by Theiler's virus.
    Azoulay A; Brahic M; Bureau JF
    J Virol; 1994 Jun; 68(6):4049-52. PubMed ID: 8189541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonequivalence of classical MHC class I loci in ability to direct effective antiviral immunity.
    Pavelko KD; Mendez-Fernandez Y; Bell MP; Hansen MJ; Johnson AJ; David CS; Rodriguez M; Pease LR
    PLoS Pathog; 2012 Feb; 8(2):e1002541. PubMed ID: 22383876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human class I major histocompatibility complex alleles determine central nervous system injury versus repair.
    Wootla B; Denic A; Watzlawik JO; Warrington AE; Zoecklein LJ; Papke-Norton LM; David C; Rodriguez M
    J Neuroinflammation; 2016 Nov; 13(1):293. PubMed ID: 27855706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-specific CD8+ T cells mediate a peptide-induced fatal syndrome.
    Johnson AJ; Mendez-Fernandez Y; Moyer AM; Sloma CR; Pirko I; Block MS; Rodriguez M; Pease LR
    J Immunol; 2005 Jun; 174(11):6854-62. PubMed ID: 15905527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.